The Power of Informed CHOICE: Why BRCA decision-making matters

Receiving a BRCA1 or BRCA2 mutation result is a turning point. It brings a new awareness of future health risks, with lifetime breast cancer risk reaching up to 72%. For many women, this also includes the possibility of more aggressive forms of the disease, such as triple-negative breast cancer. What follows is not a single decision, but a series of choices that shape long-term health and well-being.

These decisions are often made under uncertainty and emotional pressure. Options such as enhanced screening, preventive surgery, or lifestyle changes each carry different implications. The difficulty is not the absence of choices, but making sense of complex and often overwhelming information.

How can the CHOICE Project help this process?

The CHOICE Project is designed to make this process more manageable. It translates complex genetic and medical information into clear, personalized insights that women can use in their decision-making. The goal is to support decisions that feel informed and grounded in scientific research. By combining evidence-based guidance with AI-driven tools and multilingual resources, the project helps reduce barriers linked to language, access, and health literacy, as a key part of prevention and long-term care.